Incidence of hemodynamic depression after carotid artery stenting using different self-expandable stent types

Kouhei Nii1, Masanori Tsutsumi, Hiroshi Aikawa

  • 1Department of Neurosurgery, Fukuoka University Chikushi Hospital, Chikushino, Fukuoka, Japan.

Insights

The type of self-expandable stent used in carotid artery stenting (CAS) may influence hemodynamic depression (HD) risk. Researchers compared Wallstent and Precise stents, finding a significant difference in postprocedural HD rates.

Area of Science:

  • Cardiovascular Surgery
  • Interventional Neurology
  • Biomedical Engineering

Background:

  • Severe carotid artery stenosis poses a significant risk of stroke.
  • Carotid artery stenting (CAS) is a common treatment for severe carotid artery stenosis.
  • Different stent designs may impact procedural outcomes.

Purpose of the Study:

  • To compare the rates of hemodynamic depression (HD) and thromboembolism between two types of self-expandable stents during CAS.
  • To evaluate the safety and efficacy of Wallstent (braided Elgiloy) versus Precise (slotted-tube Nitinol) stents in patients with severe carotid artery stenosis.

Main Methods:

  • A comparative study of 95 CAS procedures in 87 patients with severe carotid artery stenosis.
  • Patients received either Wallstent (52 procedures) or Precise stents (43 procedures).
  • Hemodynamic parameters (blood pressure, pulse rate, neurological signs) and diffusion-weighted MRI for thromboembolism were assessed post-procedure.

Main Results:

  • The overall incidence of hypotension, bradycardia, or both was 17.9%, 3.2%, and 11.6%, respectively.
  • Postprocedural hemodynamic depression (HD) occurred in 23.1% of Wallstent procedures versus 44.2% of Precise stent procedures (p = 0.025).
  • Thromboembolism rates were 26.9% for Wallstent and 34.9% for Precise stents, a non-significant difference.

Conclusions:

  • The choice of self-expandable stent may influence the risk of procedural hemodynamic depression in CAS.
  • Postprocedural HD was successfully managed with vasopressors and withholding antihypertensive agents.
  • No major cardiovascular events were observed in any patient post-CAS.

Related Concept Videos